1. Home
  2. LSCC vs RGEN Comparison

LSCC vs RGEN Comparison

Compare LSCC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSCC
  • RGEN
  • Stock Information
  • Founded
  • LSCC 1983
  • RGEN 1981
  • Country
  • LSCC United States
  • RGEN United States
  • Employees
  • LSCC N/A
  • RGEN N/A
  • Industry
  • LSCC Semiconductors
  • RGEN Medical/Dental Instruments
  • Sector
  • LSCC Technology
  • RGEN Health Care
  • Exchange
  • LSCC Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • LSCC 8.4B
  • RGEN 8.0B
  • IPO Year
  • LSCC 1989
  • RGEN N/A
  • Fundamental
  • Price
  • LSCC $52.53
  • RGEN $126.50
  • Analyst Decision
  • LSCC Strong Buy
  • RGEN Buy
  • Analyst Count
  • LSCC 13
  • RGEN 12
  • Target Price
  • LSCC $65.46
  • RGEN $172.67
  • AVG Volume (30 Days)
  • LSCC 2.9M
  • RGEN 815.5K
  • Earning Date
  • LSCC 05-05-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • LSCC N/A
  • RGEN N/A
  • EPS Growth
  • LSCC N/A
  • RGEN N/A
  • EPS
  • LSCC 0.37
  • RGEN N/A
  • Revenue
  • LSCC $488,736,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • LSCC $3.50
  • RGEN $13.93
  • Revenue Next Year
  • LSCC $18.74
  • RGEN $14.35
  • P/E Ratio
  • LSCC $141.99
  • RGEN N/A
  • Revenue Growth
  • LSCC N/A
  • RGEN 4.88
  • 52 Week Low
  • LSCC $34.69
  • RGEN $102.97
  • 52 Week High
  • LSCC $78.29
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • LSCC 54.53
  • RGEN 44.61
  • Support Level
  • LSCC $45.17
  • RGEN $123.10
  • Resistance Level
  • LSCC $57.23
  • RGEN $135.47
  • Average True Range (ATR)
  • LSCC 2.37
  • RGEN 6.98
  • MACD
  • LSCC 0.75
  • RGEN -0.97
  • Stochastic Oscillator
  • LSCC 61.03
  • RGEN 25.20

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: